Lu, Xin

Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. [electronic resource] - BMC musculoskeletal disorders Sep 2018 - 322 p. digital

Publication Type: Journal Article; Meta-Analysis; Systematic Review

1471-2474

10.1186/s12891-018-2215-3 doi


Adult
Aged
Aged, 80 and over
Anticoagulants--adverse effects
Antithrombins--therapeutic use
Arthroplasty, Replacement, Hip--adverse effects
Arthroplasty, Replacement, Knee--adverse effects
Factor Xa Inhibitors--therapeutic use
Female
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Heparin, Low-Molecular-Weight--adverse effects
Humans
Male
Middle Aged
Pulmonary Embolism--diagnosis
Risk Factors
Treatment Outcome
Venous Thromboembolism--diagnosis
Venous Thrombosis--diagnosis